| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
73,583,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
1,917,000 |
Avg
Vol: |
869,943 |
| 52
Week Range: |
$259.55 - $259.55 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tan Heow |
Chief Quality&Tech Operations |
• – – |
2014-08-13 |
4 |
S |
$123.58 |
$1,235,808 |
D/D |
(10,000) |
1,873 |
|
- |
|
| Tan Heow |
Chief Quality&Tech Operations |
• – – |
2014-08-13 |
4 |
OE |
$27.05 |
$270,500 |
D/D |
10,000 |
11,873 |
|
- |
|
| Mcgreivy Jesse |
Chief Medical Officer |
• – – |
2014-08-07 |
4 |
S |
$120.92 |
$4,118,610 |
D/D |
(34,062) |
0 |
|
- |
|
| Mcgreivy Jesse |
Chief Medical Officer |
• – – |
2014-08-07 |
4 |
OE |
$25.33 |
$2,489,515 |
D/D |
34,062 |
34,062 |
|
- |
|
| Soni Manmeet Singh |
Chief Financial Officer |
• – – |
2014-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
38,610 |
|
- |
|
| Sjovall Boultbee Paula S |
EVP, Sales and Marketing |
• – – |
2014-05-08 |
4 |
OE |
$25.94 |
$199,997 |
D/D |
7,710 |
9,653 |
|
- |
|
| Fardis Maria |
Chief of Oncology Ops & Allian |
• – – |
2014-04-30 |
4 |
A |
$80.39 |
$16,400 |
D/D |
204 |
3,192 |
|
- |
|
| Love Richard B |
General Counsel |
• – – |
2014-04-30 |
4 |
A |
$80.39 |
$16,400 |
D/D |
204 |
204 |
|
- |
|
| Tan Heow |
Chief Quality&Tech Operations |
• – – |
2014-04-30 |
4 |
A |
$80.39 |
$16,400 |
D/D |
204 |
1,873 |
|
- |
|
| Zanganeh Maky |
Chief Operating Officer |
• – – |
2014-04-30 |
4 |
A |
$80.39 |
$16,400 |
D/D |
204 |
210,311 |
|
- |
|
| Soni Manmeet Singh |
Chief Financial Officer |
• – – |
2014-04-30 |
4 |
A |
$80.39 |
$16,400 |
D/D |
204 |
32,610 |
|
- |
|
| Outten Matthew |
VP, Commercial Operations |
• – – |
2014-04-30 |
4 |
A |
$80.39 |
$16,400 |
D/D |
204 |
10,758 |
|
- |
|
| Erdtmann Rainer M |
Sr. VP, IR and Admin |
• – – |
2014-04-30 |
4 |
A |
$80.39 |
$16,400 |
D/D |
204 |
5,701 |
|
- |
|
| Sjovall Boultbee Paula S |
EVP, Sales and Marketing |
• – – |
2014-04-30 |
4 |
A |
$80.39 |
$16,400 |
I/I |
204 |
2,932 |
|
- |
|
| Sjovall Boultbee Paula S |
EVP, Sales and Marketing |
• – – |
2014-04-30 |
4 |
A |
$80.39 |
$16,400 |
D/D |
204 |
1,943 |
|
- |
|
| Sjovall Boultbee Paula S |
EVP, Sales and Marketing |
• – – |
2014-04-29 |
4 |
OE |
$57.16 |
$133,297 |
I/I |
2,332 |
2,728 |
|
- |
|
| Duggan Robert W |
Chairman and CEO |
• • • |
2014-03-14 |
5 |
GD |
$0.00 |
$0 |
D/D |
37,926 |
13,453,452 |
|
- |
|
| Outten Matthew |
VP, Commercial OperationsOffic |
• – – |
2014-03-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
180 |
|
- |
|
| Outten Matthew |
VP, Commercial OperationsOffic |
• – – |
2014-03-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,554 |
|
- |
|
| Fardis Maria |
Chief of Oncology Ops & Allian |
• – – |
2014-03-05 |
4 |
S |
$140.50 |
$421,504 |
D/D |
(3,000) |
2,988 |
|
- |
|
| Fardis Maria |
Chief of Oncology Ops & Allian |
• – – |
2014-03-05 |
4 |
OE |
$6.84 |
$20,520 |
D/D |
3,000 |
5,988 |
|
- |
|
| Hemmi Gregory |
Sr. VP Chemical Operations |
• – – |
2014-03-05 |
4 |
S |
$140.00 |
$2,100,033 |
D/D |
(15,000) |
38,004 |
|
- |
|
| Hemmi Gregory |
Sr. VP Chemical Operations |
• – – |
2014-03-05 |
4 |
OE |
$0.86 |
$12,900 |
D/D |
15,000 |
53,004 |
|
- |
|
| Mcgreivy Jesse |
Chief Medical Officer |
• – – |
2014-03-05 |
4 |
S |
$139.66 |
$916,599 |
D/D |
(6,563) |
0 |
|
- |
|
| Mcgreivy Jesse |
Chief Medical Officer |
• – – |
2014-03-05 |
4 |
OE |
$25.33 |
$166,241 |
D/D |
6,563 |
6,563 |
|
- |
|
430 Records found
|
|
Page 4 of 18 |
|
|
